Background
"If the 20th century was the era of drug therapy, then the 21st century is the era of cell therapy," George Daley said, a biologist from the USA. Cell and gene therapies (CGT), represented by CAR-T, have shown tremendous potential in many diseases, especially cancer and genetic diseases, giving rise to the CGCT. In the past two forums, we have discussed cutting-edge technology, built an industry chain for T-cell therapy production and clinical applications, and explored emerging cell therapies, gene editing and therapy, mRNA drug development and production, and oncolytic virotherapy. Nearly 2,000 participants have gained a lot.
The CGCT forum always escorts practitioners in the cell and gene industry. The Third China Gene & Cell Therapy Innovation Forum (CGCT 2023), jointly organized by Professional Committee of Medical Engineering Transformation and Healthcare Industry Integration of China Research Hospital Association,Porton Advanced, BioValley, and BioBAY, will be held in Suzhou on June 9th. to June 10th., 2023. We will continue to focus on the forefront of Chinese cellular and genetic immunotherapy academically, explore and share new achievements in CGT with all parties and discuss the new era of the CGT field in a broader manner.
The commercialization of drugs is the closest link between drugs and ordinary patients, while CGT in combination therapy makes up for the deficiencies and is a thorough way to conquer diseases. Therefore, we will share and discuss drug commercialization strategies on combination therapy, covering the whole stage of CGT from the development of cutting-edge technology to industrial cooperation, which is also the goal of the CGCT forum. The conference will also invite well-known capital investors to join forces with colleagues from the industry, allowing all participants to leave satisfied and helping the colleagues in the CGT industry to develop together and create brilliance.
In the misty and rainy south of the Yangtze river, we return to the time-honored city - Suzhou. May new success in 2023!
Brief
Formu:The Third China Gene & Cell Therapy Innovation Forum
Theme:Accelerating the Transition into the Clinic and Beyond
Guider:National Center of Technology Innovation for Biopharmaceuticals
Organizers:Professional Committee of Medical Engineering Transformation and Healthcare Industry Integration of China Research Hospital Association,Porton Advanced, BioValley, BioBAY
Co-Organizer:University of Shanghai for Science and Technology-Shanghai Jiao Tong University School of Medicine, Institute for Interdisciplinary Innovation - Suzhou Institute of Biomedical Engineering and Technology
Supporting organizers:"Innovation China" Sci-Tech Service Team for Biopharmaceutical Industry, Chinese Biopharmaceutical Association - CBA
Time:June. 9th-10th. 2023
Place:Suzhou, Jiangsu Province
Scale:1000人
Highlights

Participants of the previous conference
